The effects of Vitamin K supplementation and Vitamin K antagonists on progression of vascular calcification: Ongoing randomized controlled trials

Clinical Kidney Journal

Volumn 9, Issue 2, 2016, Pages 273-279

  Caluwé, Rogier ^a   Pyfferoen, Lotte ^b   De Boeck, Koen ^c   De Vriese, An S ^d  

^a OLV HOSPITAL   (Belgium)

^b AZ Sint Jan Brugge ^*  (Belgium)

^c ZNA Hospitals   (Belgium)

^d Division of Nephrology and Infectious Diseases   (Belgium)

Author keywords

haemodialysis; rivaroxaban; vascular calcifications; Vitamin K; Vitamin K antagonists

Indexed keywords

APIXABAN; FARNOQUINONE; PHYTOMENADIONE; RIVAROXABAN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; FEMALE; HEMODIALYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE CALCIFICATION; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; THORACIC AORTA CALCIFICATION; VITAMIN SUPPLEMENTATION;

EID: 84963940169     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv146     Document Type: Article

References (42)

1. Bellasi A, Raggi P. Vascular imaging in chronic kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 382-388
2. Brandenburg VM, Schurgers LJ, Kaesler N, et al. Prevention of vasculopathy by vitamin K supplementation: canwe turn fiction into fact?. Atherosclerosis 2015; 240: 10-16
3. Cranenburg ECM, Schurgers LJ, Uiterwijk HH, et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012; 82: 605-610
4. Caluwé R, Vandecasteele S, Van Vlem B, et al. Vitamin K2 supplementation in haemodialysis patients: a randomized dosefinding study. Nephrol Dial Transplant 2013; 29: 1385-1390
5. Kaesler N, Magdeleyns E, Herfs M, et al. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int 2014; 86: 286-293
6. Schurgers LJ, Barreto DV, Barreto FC, et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010; 5: 568-575
7. Westenfeld R, Krueger T, Schlieper G, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195
8. Pucaj K, Rasmussen H, Møller M, et al. Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7. Toxicol Mech Methods 2011; 21: 520-532
9. Theuwissen E, Cranenburg EC, Knapen MH, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 2012; 108: 1652-1657
10. Inoue T, Fujita T, Kishimoto H, et al. Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab 2009; 27: 66-75
11. Vissers LET, Dalmeijer GW, Boer JMA, et al. Intake of dietary phylloquinone and menaquinones and risk of stroke. J Am Heart Assoc 2013; 2: e000455-e000455
12. Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe?. AdvNutr 2012; 3: 149-157
13. Winkelmayer WC, Patrick AR, Liu J, et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011; 22: 349-357
14. Zhang Y-T, Tang Z-Y. Research progress of warfarinassociated vascular calcification and its possible therapy. J Cardiovasc Pharmacol 2014; 63: 76-82
15. Krüger T, Floege J. Vitamin K antagonists: beyond bleeding. Semin Dial 2014; 27: 37-41
16. Fusaro M, Tripepi G, Noale M, et al. Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 2015; 13: 248-258
17. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891
18. De Vriese AS, Caluwé R, Bailleul E, et al. Dose-finding study of rivaroxaban in hemodialysis patients. Am J Kidney Dis 2015; 66: 91-98
19. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1-e76
20. Langou RA, Huang EK, Kelley MJ, et al. Predictive accuracy of coronary artery calcification and abnormal exercise test for coronary artery disease in asymptomatic men. Circulation 1980; 62: 1196-1203
21. Verbeke F, Van Biesen W, Honkanen E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the Calcification Outcome in Renal Disease (CORD) Study. Clin J Am Soc Nephrol 2011; 6: 153-159
22. Cranenburg E, Koos R, Schurgers LJ, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010; 104: 811-822
23. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832
24. Callister TQ, Cooil B, Raya SP, et al. Coronary artery disease: improved reproducibility of calcium scoring with an electronbeam CT volumetric method. Radiology 1998; 208: 807-814
25. Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-448
26. Di Iorio B, Nazzaro P, Cucciniello E, et al. Influence of haemodialysis on variability of pulse wave velocity in chronic haemodialysis patients. Nephrol Dial Transplant 2010; 25: 1579-1583
27. Chertow GM, Burke SK, Raggi P, Treat to GoalWorking Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
28. Barreto DV, Barreto F de C, de Carvalho AB, et al. Phosphate binder impact on bone remodeling and coronary calcification-results from the BRiC study. Nephron Clin Pract 2008; 110: c273-c283
29. Qunibi W, Moustafa M, Muenz LR, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965
30. Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011; 26: 1327-1339
31. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105
32. Beulens JWJ, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009; 203: 489-493
33. Gast GCM, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009; 19: 504-510
34. Maas AHEM, van der Schouw YT, Beijerinck D, et al. Vitamin K intake and calcifications in breast arteries. Maturitas 2007; 56: 273-279
35. Villines TC, Hatzigeorgiou C, Feuerstein IM, et al. Vitamin K1 intake and coronary calcification. Coron Artery Dis 2005; 16: 199
36. Fusaro M, Noale M, Viola V, et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012; 27: 2271-2278
37. Shea MK, O'Donnell CJ, Hoffmann U, et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009; 89: 1799-1807
38. Braam LAJLM, Hoeks APG, Brouns F, et al. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004; 91: 373-380
39. Shea MK, O'Donnell CJ, Vermeer C, et al. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011; 141: 1529-1534
40. Knapen MHJ, Braam LAJLM, Drummen NE, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb Haemost 2015; 113: 1135-1144
41. Kurnatowska I, Grzelak P, Masajtis-Zagajewska A. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in non-dialyzed patients with chronic kidney disease stage 3-5. Pol Arch Med Wewn 2015; 125: 631-640
42. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-Analysis of randomised trials. Lancet 2014; 383: 955-962